Therapeutic potential and molecular mechanisms of citrus flavonoids in hepatocellular carcinoma
Authors:
Open Access
- 25 August 2026
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 17, 1848561
Abstract
Citrus-derived flavonoids, particularly naringenin, hesperidin, and hesperetin, have emerged as promising bioactive compounds with potential therapeutic relevance in hepatocellular carcinoma (HCC). This review provides a focused synthesis of current preclinical evidence regarding their anticancer properties and underlying molecular mechanisms in experimental HCC models. These flavonoids exert broad anticancer effects, including inhibition of cell proliferation, induction of apoptosis, reduction of oxidative stress, and suppression of tumor progression and metastasis. These activities are mediated through modulation of key oncogenic signaling pathways, which are critically involved in hepatocarcinogenesis. In addition, citrus flavonoids influence mitochondrial function and cellular redox homeostasis, thereby contributing to programmed cell death and metabolic regulation. Preclinical studies further indicate that these compounds may enhance the efficacy of conventional chemotherapeutic agents, including cisplatin, doxorubicin, and sorafenib, while exhibiting reduced toxicity toward normal cells. Moreover, nanoformulation-based delivery systems have been shown to improve their bioavailability and therapeutic performance in experimental models. In vivo evidence supports their hepatoprotective effects, with reductions in tumor burden and attenuation of inflammation and fibrosis. Collectively, citrus flavonoids represent promising adjunctive candidates for HCC therapy; however, clinical validation remains limited, and further translational studies are required to confirm their therapeutic applicability in humans.Keywords
This publication has 74 references indexed in Scilit:
- Unrevealing the Multifaceted Role of Resveratrol as Potential Antioxidant and Anticancer Agent: Molecular Mechanism and Future PerspectivesChemistry & Biodiversity, 2026
- Metabolic Reprogramming in Lung Cancer: Hallmarks, Mechanisms, and Targeted Strategies to Overcome Immune ResistanceCancer Medicine, 2025
- Autophagy‐induced cell death by aqueous and polyphenol‐enriched extracts of honeybush ( Cyclopia spp.) in liver and colon cancer cellsFood Science & Nutrition, 2024
- Epidemiology of Hepatocellular CarcinomaHepatology, 2020
- Hesperidin‐CAMKIV interaction and its impact on cell proliferation and apoptosis in the human hepatic carcinoma and neuroblastoma cellsJournal of Cellular Biochemistry, 2019
- Involvement of PI3K/Akt pathway in the protective effect of hesperidin against a chemically induced liver cancer in ratsJournal of Biochemical and Molecular Toxicology, 2019
- Demethylating and anti‐hepatocarcinogenic potential of hesperidin, a natural polyphenol of Citrus juicesMolecular Carcinogenesis, 2017
- Mitochondrial Dysfunction and Ca2+ Overload Contributes to Hesperidin Induced Paraptosis in Hepatoblastoma Cells, HepG2Journal of Cellular Physiology, 2015
- Hesperetin induces the apoptosis of hepatocellular carcinoma cells via mitochondrial pathway mediated by the increased intracellular reactive oxygen species, ATP and calciumMedical Oncology, 2015
- Suppression of CYP1A1 expression by naringenin in murine Hepa-1c1c7 cellsArchives of Pharmacal Research, 2004